Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196 · see citing works

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · see citing works

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,610 · see citing works

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat

Pellow, S., & File, S. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90552-6 · Cited by 1,534 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Modulation of anxiety through blockade of anandamide hydrolysis

Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · see citing works

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works

Targeting the endocannabinoid system: to enhance or reduce?

Marzo, V. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798 · see citing works

An endocannabinoid mechanism for stress-induced analgesia

Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · see citing works

Central circuits mediating patterned autonomic activity during active vs. passive emotional coping

Bandler, R., Keay, K. A., Floyd, N., & Price, J. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00313-0 · Cited by 582 · see citing works

Endocannabinoid system and stress and anxiety responses

VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485 · see citing works

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.

Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 478 · see citing works

The endocannabinoid system: a general view and latest additions

PETROCELLIS, L. D., Cascio, M. G., & Marzo, V. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705666 · Cited by 473 · see citing works

Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling

Patel, S., & Hillard, C. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101287 · Cited by 390 · see citing works

Comparative analysis of fatty acid amide hydrolase and cb1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling

Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347 · see citing works

A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation

Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 319 · see citing works

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

Pertwee, R. G. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00108.x · Cited by 314 · see citing works

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312 · see citing works

Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling

Patel, S., Roelke, C. T., Rademacher, D. J., & Hillard, C. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03916.x · Cited by 297 · see citing works

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

Moreira, F. A., Kaiser, N., Monory, K., & Lutz, B. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.005 · Cited by 282 · see citing works

Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses

Busquets-Garcia, A., Puighermanal, E., Pastor, A., de la Torre, R., Maldonado, R., & Ozaita, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.022 · Cited by 273 · see citing works

Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404

Bortolato, M., Campolongo, P., Mangieri, R. A., Scattoni, M. L., Frau, R., Trezza, V., Rana, G. L., Russo, R., Calignano, A., Gessa, G. L., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301061 · Cited by 233 · see citing works

Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol

Berrendero, F., & Maldonado, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 221 · see citing works

On serotonin and experimental anxiety

Graeff, F. G. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1112-4 · Cited by 219 · see citing works

A novel probe for the cannabinoid receptor

Devane, W. A., Breuer, A., Sheskin, T., Jaerbe, T. U. C., Eisen, M. S., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a018 · Cited by 205 · see citing works

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

Ortega-Álvaro, A., Aracil-Fernández, A., García‐Gutiérrez, M. S., Navarrete, F., & Manzanares, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.34 · Cited by 187 · see citing works

Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain

Onaivi, E. S. (2006) · Neuropsychobiology · doi:10.1159/000100778 · Cited by 187 · see citing works

Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats

Sciolino, N. R., Zhou, W., & Hohmann, A. G. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.010 · Cited by 179 · see citing works

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour

Rubino, T., Guidali, C., Viganò, D., Realini, N., Valenti, M., Massi, P., & Parolaro, D. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.024 · Cited by 179 · see citing works

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay

Kinsey, S. G., O'Neal, S. T., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.002 · Cited by 170 · see citing works

Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation

Patel, S., & Hillard, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06266.x · Cited by 162 · see citing works

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

García-Gutiérrez, M. S., & Manzanares, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379507 · Cited by 153 · see citing works

Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey

Guimarães, F. S., Carobrez, A. P., Aguiar, J. C. D., & Graeff, F. G. (1991) · Psychopharmacology · doi:10.1007/bf02244080 · Cited by 151 · see citing works

Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray

Moreira, F. A., de Aguiar, D. C., & Guimarães, F. S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.013 · Cited by 149 · see citing works

Cellular Mechanisms Underlying the Anxiolytic Effect of Low Doses of Peripheral Δ9-Tetrahydrocannabinol in Rats

Rubino, T., Sala, M., Viganò, D., Braida, D., Castiglioni, C., Limonta, V., Guidali, C., Realini, N., & Parolaro, D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301330 · Cited by 137 · see citing works

Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats

Finn, D. P., Jhaveri, M. D., Beckett, S. R. G., Roe, C. H., Kendall, D. A., Marsden, C. A., & Chapman, V. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00235-1 · Cited by 136 · see citing works

Endocannabinoid signals in the control of emotion

Lutz, B. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.001 · Cited by 124 · see citing works

Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats

Casarotto, P. C., Terzian, A. L. B., Aguiar, D. C., Zangrossi, H., Guimarães, F. S., Wotjak, C. T., & Moreira, F. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.207 · Cited by 117 · see citing works

Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety—two sides of one coin?

Moreira, F. A., de Aguiar, D. C., Terzian, A. L. B., Guimarães, F. S., & Wotjak, C. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.046 · Cited by 112 · see citing works

The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior

Fogaça, M. V., de Aguiar, D. C., Moreira, F. A., & Guimarães, F. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.007 · Cited by 89 · see citing works

Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase- Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia

Gregg, L. C., Jung, K., Spradley, J. M., Nyilas, R., Suplita, R. L., Zimmer, A., Watanabe, M., Mackie, K., Katona, I., Piomelli, D., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0013-12.2012 · Cited by 79 · see citing works

Characterization and Localization of Cannabinoid Receptors in Brain: An In Vitro Technique Using Slide-Mounted Tissue Sections

Herkenham, M. A. (1991) · PsycEXTRA Dataset · doi:10.1037/e496242006-009 · Cited by 76 · see citing works

Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats

Resstel, L. B. M., Lisboa, S. F. D. S., de Aguiar, D. C., Corrêa, F. M. D. A., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1156-1 · Cited by 75 · see citing works

Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test

Lisboa, S. F. D. S., Resstel, L. B. M., de Aguiar, D. C., & Guimarães, F. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.032 · Cited by 66 · see citing works

Flight reactions induced by injection of glutamate N-methyl-d-aspartate receptor agonist into the rat dorsolateral periaqueductal gray are not dependent on endogenous nitric oxide

de Aguiar, D. C., Moreira, F. A., & Guimarães, F. S. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.02.010 · Cited by 39 · see citing works

The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature

Aliczki, M., Balogh, Z., Tulogdi, A., & Haller, J. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283564dfa · Cited by 37 · see citing works

The endocannabinoid system in guarding against fear, anxiety and stress

Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4036 · Cited by 506 · see citing works

Control of Stress-Induced Persistent Anxiety by an Extra-Amygdala Septohypothalamic Circuit

Anthony, T. E., Dee, N., Bernard, A., Lerchner, W., Heintz, N., & Anderson, D. J. (2014) · Cell · doi:10.1016/j.cell.2013.12.040 · Cited by 310 · see citing works

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors

Bakas, T., van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.022 · Cited by 246 · see citing works

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder

Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.162 · Cited by 239 · see citing works

Endocannabinoid System Components as Potential Biomarkers in Psychiatry

Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 134 · see citing works

2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons

Llorente‐Berzal, A., Terzian, A. L. B., Marzo, V. D., Micale, V., Viveros, M., & Wotjak, C. T. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3917-y · Cited by 107 · see citing works

Diet-Induced Changes in n-3- and n-6-Derived Endocannabinoids and Reductions in Headache Pain and Psychological Distress

Ramsden, C. E., Zamora, D., Makriyannis, A., Wood, J. T., Mann, J. D., Faurot, K. R., MacIntosh, B., Majchrzak‐Hong, S. F., Gross, J. R., Courville, A. B., et al. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.04.007 · Cited by 75 · see citing works

Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache

Ramsden, C. E., Faurot, K. R., Zamora, D., Palsson, O. S., MacIntosh, B., Gaylord, S. A., Taha, A. Y., Rapoport, S. I., Hibbeln, J. R., Davis, J. M., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460348.84965.47 · Cited by 72 · see citing works

Endocannabinoids and Mental Disorders

Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 71 · see citing works

Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats

Manduca, A., Morena, M., Campolongo, P., Servadio, M., Palmery, M., Trabace, L., Hill, M. N., Vanderschuren, L. J. M. J., Cuomo, V., & Trezza, V. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.005 · Cited by 67 · see citing works

Developmental regulation of fear learning and anxiety behavior by endocannabinoids

Lee, T. T.-Y., Hill, M. N., & Lee, F. S. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12253 · Cited by 67 · see citing works

Developing ‘integrative’ zebrafish models of behavioral and metabolic disorders

Nguyen, M., Yang, E., Neelkantan, N., Mikhaylova, A., Arnold, R., Poudel, M. K., Stewart, A., & Kalueff, A. V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.012 · Cited by 59 · see citing works

The Endocannabinoid System and Anxiety

Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56 · see citing works

Anxiolytic- and antidepressant-like effects of angiotensin-(1–7) in hypertensive transgenic (mRen2)27 rats

Almeida-Santos, A. F., Kangussu, L. M., Moreira, F. A., Santos, R. A. S., de Aguiar, D. C., & Campagnole‐Santos, M. J. (2016) · Clinical Science · doi:10.1042/cs20160116 · Cited by 51 · see citing works

Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear

Ivy, D. M., Palese, F., Vozella, V., Fotio, Y., Yalcin, A., Ramirez, G. L., Mears, D. J., Wynn, G. H., & Piomelli, D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0696-x · Cited by 47 · see citing works

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine

Greco, R., Demartini, C., Francavilla, M., Zanaboni, A. M., & Tassorelli, C. (2021) · Cells · doi:10.3390/cells10102543 · Cited by 42 · see citing works

Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs

Batista, L. A., Gobira, P. H., Viana, T. G., de Aguiar, D. C., & Moreira, F. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000073 · Cited by 38 · see citing works

Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors

Olmo, I. G., Ferreira-Vieira, T. H., & Ribeiro, F. M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104372 · Cited by 28 · see citing works

Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL ‐α, induces autism spectrum disorder‐like and co‐morbid phenotypes in adult C57BL /J mice

Fyke, W., Alarcón, J. M., Velinov, M. T., & Chadman, K. K. (2021) · Autism Research · doi:10.1002/aur.2520 · Cited by 19 · see citing works

Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks

Viana, T. G., Bastos, J. D. R., Briânis, R. C., Hott, S. C., Machado, F. S. M., Coimbra, C. C., Resstel, L. B. M., de Aguiar, D. C., & Moreira, F. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.022 · Cited by 17 · see citing works

Attenuation of fear‐conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB2 receptors

Corcoran, L., Mattimoe, D., Roche, M., & Finn, D. P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14976 · Cited by 16 · see citing works

The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain

Zhang, M., Wang, T., Meng, F., Jiang, M., Wu, S., & Xu, H. (2024) · iScience · doi:10.1016/j.isci.2024.111409 · Cited by 16 · see citing works

Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses

Batista, L. A., Bastos, J. D. R., & Moreira, F. A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114566259 · Cited by 15 · see citing works

2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex

Almeida‐Santos, A. F., Moreira, F. A., Guimarães, F. S., & de Aguiar, D. C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117704986 · Cited by 11 · see citing works

Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors

Leonard, M. Z., Alapafuja, S. O., Ji, L., Shukla, V. G., Liu, Y., Nikas, S. P., Makriyannis, A., Bergman, J., & Kangas, B. D. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244392 · Cited by 10 · see citing works

Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.

Moghaddam, A. H., Bigdellu, R., Tabatabaei, S. R. F., & Roohbakhsh, A. (2013) · PubMed · Cited by 10 · see citing works

Role of endocannabinoid neurotransmission in the insular cortex on cardiovascular, autonomic and behavioral responses evoked by acute restraint stress in rats

Belém-Filho, I. J. A., de Godoy, A. C. V., Busnardo, C., Frias, A. T., Zangrossi, H., Borges, B. D. B., Herval, A. C. F., Corrêa, F. M. D. A., Crestani, C. C., & Alves, F. H. F. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110404 · Cited by 9 · see citing works

Repeated Mild Traumatic Brain Injury and JZL184 Produce Sex-Specific Increases in Anxiety-Like Behavior and Alcohol Consumption in Wistar Rats

Jacotte-Simancas, A., Molina, P. E., & Gilpin, N. W. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2023.0088 · Cited by 8 · see citing works

Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation

Batista, L. A., & Moreira, F. A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.010 · Cited by 8 · see citing works

Fatty acid binding proteins and their involvement in anxiety and mood disorders

Jones, M., Uzuneser, T. C., & Laviolette, S. R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106952 · Cited by 6 · see citing works

Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception

Godoi, M. M., Zangrossi, H., da Cunha, J. M., & Zanoveli, J. M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172938 · Cited by 5 · see citing works

Interactions Between Cannabinoid Signaling and Anxiety: A Comparative Analysis of Intervention Tools and Behavioral Effects

Aliczki, M., & Haller, J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_4 · Cited by 5 · see citing works

Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests

Brianis, R. C., Lima, R. C., Moreira, F. A., & Aguiar, D. C. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000639 · Cited by 3 · see citing works

Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections

da Silva, J. A., Almada, R. C., Falconi‐Sobrinho, L. L., Pigatto, G. R., Hernandes, P. M., & Coimbra, N. C. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.11.014 · Cited by 3 · see citing works

Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity

da Silva, J. A., Almada, R. C., de Paiva, Y. B., & Coimbra, N. C. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02217-8 · Cited by 3 · see citing works

ML184 influences coping strategies via GPR55-dependent mechanisms following its delivery in the periaqueductal gray (PAG) region

López-Lariz, C. H., & Marichal‐Cancino, B. A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.016 · Cited by 2 · see citing works

A Sexually Dimorphic Role for Intestinal Cannabinoid Receptor Subtype-1 in the Behavioral Expression of Anxiety

Wood, C. P., Avalos, B., Alvarez, C., & DiPatrizio, N. V. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0150 · Cited by 2 · see citing works

The innate defensive behaviour and unconditioned fear-induced antinociception evoked by NMDA receptor activation in the medial hypothalamus are modulated by the intradiencephalic treatment with cannabidiol: the role of CB1 cannabinoid receptor

Khan, A. U. (2019) · doi:10.11606/t.17.2019.tde-29042019-162811

Participação do sistema endocanabinoide do núcleo do leito da estria terminal na modulação da resposta emocional condicionada em ratos: participação das neurotransmissões glutamatérgica e nitrérgica

de Assis, A. B. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11042022-135852

JZL184 increases anxiety-like behavior and does not reduce alcohol consumption in female rats after repeated mild traumatic brain injuryPreprint

Jacotte-Simancas, A., Molina, P. E., & Gilpin, N. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.30.542943

Identifying therapeutic targets for the treatment of Fragile X Syndrome : Implications for Autism Spectrum Disorders

Fyke, W. (2021) · doi:10.70675/6c9f3127z6aa3z47f2z8641z781aefb3c203

Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests

Brianis, R. C., Lima, R. C., Moreira, F. A., & Aguiar, D. C. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000639 · Cited by 3 · see citing works

Participação do endocanabinoide 2-araquidonoilglicerol (2-AG) nas respostas defensivas mediadas pela substância cinzenta periaquedutal dorsolateral e pelo córtex pré-frontal ventromedial

Almeida, A. F. S. (2015) · Americanae (AECID Library)

Efeito do 2-Araquidonoilglicerol nas respostas defensivas mediadas pela substância cinzenta periaquedutal dorsolateral de ratos em modelos animais de ansiedade

Lima, R. D. C. D. O. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey

Gobira, P. H., Almeida‐Santos, A. F., Guimarães, F. S., Moreira, F. A., & de Aguiar, D. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.014 · Cited by 12 · see citing works

Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray

Moreira, F. A., de Aguiar, D. C., & Guimarães, F. S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.013 · Cited by 149 · see citing works